| 1. To estimate the coverage of the three main components of DAMaN that includes |
1a. Coverage of MSAT, a component of DAMaN will be estimated along with MSAT’s test positivity rate proportion of asymptomatic among positives etc. This will be done from DAMaN project information system data. |
| a) mass screening and treatment (MSAT), |
1b. A survey of DAMaN beneficiaries to be conducted (details below) and primary data from the survey will be used to estimate Long lasting Insecticidal Net (LLIN) usage and coverage of Indoor Residual Spray |
| b) vector control measures (LLIN) and c) community mobilisation and participation |
1c. Same data as 1b will be used to estimate coverage by DAMaN-related community mobilisation campaigns |
| 2. To estimate the prevalence of malaria parasites at clinical and sub-clinical (asymptomatic and sub-patent) level |
2a. Secondary data, related to MSAT, collected from DAMaN project information system for 2017 to 2019. This will help to track the trend of prevalence in parasitemia |
| 2b. DAMaN survey will include collection of blood specimens from the sampled individuals and tests to identify parasitemia and quantification of parasite gametes will be carried out. Two rounds of the survey is to be conducted which will help us to track the trend in parasitemia prevalence |
| 3. To evaluate the impact of DAMaN on fever and malaria burden as reflected in routine NVBDCP data |
Routine yearly and monthly NVBDCP data, collected from the level of the Sub-Centres, the lowest reporting units of the programme, for blood examination rate and parasite incidence for the six survey districts from 2013 to 2018 (6 years) will be analysed using appropriate variants of Difference analysis, Difference analysis across three categories of Sub-Centre stratified by the scale of DAMaN’s MSAT coverage, interrupted time-series (ITS), ITS analysis across three strata of sub-center. The sub-centres then will be stratified by their DAMaN project’s MSAT coverage data (see point 1). Then trends of NVBDCP data will be compared across the strata of Sub-Centres (hypothesis: “higher the coverage of DAMaN, steeper is the decline of malaria and fever incidence”) |
| 4. To assess the maternal and child health in terms of birth outcome, anaemia in pregnancy and nutritional status of under five children among DAMaN beneficiaries and compare with state averages |
A survey of DAMaN beneficiaries will be conducted and primary anthropometric, haemoglobin and pregnancy outcome indicators will be estimated. It will be compared with state averages of Odisha |
